These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8462613)

  • 1. N-(2-diethylaminoethyl)-4-[123I]iodobenzamide as a tracer for the detection of malignant melanoma: simple synthesis, improved labelling technique and first clinical results.
    Brandau W; Kirchner B; Bartenstein P; Sciuk J; Kamanabrou D; Schober O
    Eur J Nucl Med; 1993 Mar; 20(3):238-43. PubMed ID: 8462613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure distribution relationship of iodine-123-iodobenzamides as tracers for the detection of melanotic melanoma.
    Brandau W; Niehoff T; Pulawski P; Jonas M; Dutschka K; Sciuk J; Coenen HH; Schober O
    J Nucl Med; 1996 Nov; 37(11):1865-71. PubMed ID: 8917194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
    Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential accumulation of iodine-123-iodobenzamide in melanotic and amelanotic melanoma metastases in vivo.
    Larisch R; Schulte KW; Vosberg H; Ruzicka T; Müller-Gärtner HW
    J Nucl Med; 1998 Jun; 39(6):996-1001. PubMed ID: 9627332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 123I-N-(2-diethylaminoethyl)-2-iodobenzamide: a potential imaging agent for cutaneous melanoma staging.
    Moins N; D'Incan M; Bonafous J; Bacin F; Labarre P; Moreau MF; Mestas D; Noirault E; Chossat F; Berthommier E; Papon J; Bayle M; Souteyrand P; Madelmont JC; Veyre A
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1478-84. PubMed ID: 12397467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma].
    Sillaire-Houtmann I; Bonafous J; Veyre A; Mestas D; D'Incan M; Moins N; Kemeny JL; Chossat F; Bacin F
    J Fr Ophtalmol; 2004 Jan; 27(1):34-9. PubMed ID: 14968075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic value of 123iodine-ibzm scintigraphy for staging of malignant melanomas].
    Henker C; Bida B; Markwardt J; Schlag P
    Nuklearmedizin; 1997 Jan; 36(1):1-6. PubMed ID: 9082335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visualizing ocular melanoma using iodine-123-N-(2-diethylaminoethyl)4-iodobenzamide SPECT.
    Everaert H; Bossuyt A; Flamen P; Mertens J; Franken PR
    J Nucl Med; 1997 Jun; 38(6):870-3. PubMed ID: 9189131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).
    Michelot JM; Moreau MF; Veyre AJ; Bonafous JF; Bacin FJ; Madelmont JC; Bussiere F; Souteyrand PA; Mauclaire LP; Chossat FM
    J Nucl Med; 1993 Aug; 34(8):1260-6. PubMed ID: 8326382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radioiodinated N-(2-diethylaminoethyl)benzamide derivatives with high melanoma uptake: structure-affinity relationships, metabolic fate, and intracellular localization.
    Eisenhut M; Hull WE; Mohammed A; Mier W; Lay D; Just W; Gorgas K; Lehmann WD; Haberkorn U
    J Med Chem; 2000 Oct; 43(21):3913-22. PubMed ID: 11052796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scintigraphic detection of melanoma metastases with a radiolabeled benzamide ([iodine-123]-(S)-IBZM).
    Maffioli L; Mascheroni L; Mongioj V; Gasparini M; Baldini MT; Seregni E; Castellani MR; Cascinelli N; Buraggi GL
    J Nucl Med; 1994 Nov; 35(11):1741-7. PubMed ID: 7965150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide [1].
    Maffioli L; Chiti A; Gasparini M; Bombardieri E
    Eur J Nucl Med; 1994 Dec; 21(12):1366. PubMed ID: 7875175
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of iodine-123-IMBA for melanoma imaging.
    Nicholl C; Mohammed A; Hull WE; Bubeck B; Eisenhut M
    J Nucl Med; 1997 Jan; 38(1):127-33. PubMed ID: 8998166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, radiolabeling, and preliminary evaluation in mice of some (N-diethylaminoethyl)-4-iodobenzamide derivatives as melanoma imaging agents.
    Moreau MF; Michelot J; Papon J; Bayle M; Labarre P; Madelmont JC; Parry D; Boire JY; Moins N; Seguin H
    Nucl Med Biol; 1995 Aug; 22(6):737-47. PubMed ID: 8535334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors.
    Oltmanns D; Eisenhut M; Mier W; Haberkorn U
    Curr Med Chem; 2009; 16(17):2086-94. PubMed ID: 19519383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sigma-receptor imaging by means of I123-IDAB scintigraphy: clinical application in melanoma and non-small cell lung cancer.
    Everaert H; Flamen P; Franken PR; Verhaeghe W; Bossuyt A
    Anticancer Res; 1997; 17(3B):1577-82. PubMed ID: 9179197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of [123I] N-(2-diethylaminoethyl)-4-iodobenzamide in the diagnosis of primary and metastatic ocular melanoma.
    Bacin F; Michelot J; Bonafous J; Veyre A; Moreau MF; Kemeny JL; Chossat F; Bekhechi D
    Acta Ophthalmol Scand; 1998 Feb; 76(1):56-61. PubMed ID: 9541435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An improved synthesis of [125I]N-(diethylaminoethyl)-4-iodobenzamide: a potential ligand for imaging malignant melanoma.
    John CS; Saga T; Kinuya S; Le N; Jeong JM; Paik CH; Reba RC; Varma VM; McAfee JG
    Nucl Med Biol; 1993 Jan; 20(1):75-9. PubMed ID: 8461882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [123I]IBZM uptake in metastatic melanoma.
    Maffioli LS; Mascheroni L; Clemente C; Baldini M; Castellani MR
    J Nucl Biol Med (1991); 1993 Mar; 37(1):18-20. PubMed ID: 8329472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of melanoma lesions using ¹³¹I-IMBA obtained by electrophilic substitution of ¹³¹I for metal organic substituent - a preliminary communication.
    Janczak M; Nejc D; Bieńkiewicz M; Płachcińska A; Kuśmierek J
    Nucl Med Rev Cent East Eur; 2010; 13(2):70-5. PubMed ID: 21598230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.